Literature DB >> 20648632

Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect.

Wolfgang H Sommer1, Jessica Lidström, Hui Sun, Derek Passer, Robert Eskay, Stephen C J Parker, Stephanie H Witt, Ulrich S Zimmermann, Vanessa Nieratschker, Marcella Rietschel, Elliott H Margulies, Miklós Palkovits, Manfred Laucht, Markus Heilig.   

Abstract

Studies in humans and animals suggest a role for NPY in the mediation of behavioral stress responses. Here, we examined whether the NPY promoter variant rs16147:T>C is functional for expression of NPY in a brain region relevant for behavioral control, anxiety and depression, the anterior cingulate cortex. In silico analysis of DNA structural profile changes produced by rs16147 variation suggests allelic differences in protein binding at the rs16147 site. This was confirmed by electrophoretic mobility shift assay, demonstrating that the rs16147 C-allele has strongly reduced affinity for a yet unknown factor compared to the T-allele. Analyzing 107 human post-mortem brain samples we show that allelic variation at rs16147 contributes to regulation of NPY mRNA and peptide levels in this region. Specifically, the C-allele leads to increased gene expression. In agreement with the molecular findings, rs16147:T>C is associated with anxiety and depressive symptoms in 314 young adults via a gene x environment interaction with early childhood adversity, replicating the recent finding of rs16147-C as a risk factor for stress related psychopathology. Our results show the importance of rs16147:T>C for regulation of NPY gene expression and brain function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20648632      PMCID: PMC2908962          DOI: 10.1002/humu.21299

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  51 in total

1.  Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims.

Authors:  Yogesh Dwivedi; Amal C Mondal; Hooriyah S Rizavi; Gabor Faludi; Miklos Palkovits; Andrea Sarosi; Robert R Conley; Ghanshyam N Pandey
Journal:  Arch Gen Psychiatry       Date:  2006-06

Review 2.  Using ancestry-informative markers to define populations and detect population stratification.

Authors:  Mary-Anne Enoch; Pei-Hong Shen; Ke Xu; Colin Hodgkinson; David Goldman
Journal:  J Psychopharmacol       Date:  2006-07       Impact factor: 4.153

3.  Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress.

Authors:  A C Hansson; A Cippitelli; W H Sommer; A Fedeli; K Björk; L Soverchia; A Terasmaa; M Massi; M Heilig; R Ciccocioppo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

4.  A population-based twin study of the relationship between neuroticism and internalizing disorders.

Authors:  John M Hettema; Michael C Neale; John M Myers; Carol A Prescott; Kenneth S Kendler
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

Review 5.  The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking.

Authors:  Wolfgang Sommer; Petri Hyytiä; Kalervo Kiianmaa
Journal:  Addict Biol       Date:  2006-09       Impact factor: 4.280

Review 6.  Intermediate phenotypes and genetic mechanisms of psychiatric disorders.

Authors:  Andreas Meyer-Lindenberg; Daniel R Weinberger
Journal:  Nat Rev Neurosci       Date:  2006-10       Impact factor: 34.870

7.  CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.

Authors:  Cailan Hou; Fujun Jia; Yi Liu; Lingjiang Li
Journal:  Brain Res       Date:  2006-05-19       Impact factor: 3.252

8.  Local DNA topography correlates with functional noncoding regions of the human genome.

Authors:  Stephen C J Parker; Loren Hansen; Hatice Ozel Abaan; Thomas D Tullius; Elliott H Margulies
Journal:  Science       Date:  2009-03-12       Impact factor: 47.728

9.  Is there an association between NPY and neuroticism?

Authors:  Colleen H Cotton; Jonathan Flint; Thomas G Campbell
Journal:  Nature       Date:  2009-04-02       Impact factor: 49.962

10.  Potential genetic variants in schizophrenia: a Bayesian analysis.

Authors:  Håkan Hall; Glenn Lawyer; Anna Sillén; Erik G Jönsson; Ingrid Agartz; Lars Terenius; Stefan Arnborg
Journal:  World J Biol Psychiatry       Date:  2007       Impact factor: 4.132

View more
  32 in total

Review 1.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

Review 2.  Nonhuman primate models in the genomic era: a paradigm shift.

Authors:  Eric J Vallender; Gregory M Miller
Journal:  ILAR J       Date:  2013

3.  Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.

Authors:  Eugen Kloster; Carsten Saft; Denis A Akkad; Jörg T Epplen; Larissa Arning
Journal:  J Mol Med (Berl)       Date:  2014-02       Impact factor: 4.599

Review 4.  Neuropeptide Y and posttraumatic stress disorder.

Authors:  R Sah; T D Geracioti
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

5.  Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.

Authors:  Kuixing Zhang; Fangwen Rao; Jose Pablo Miramontes-Gonzalez; C Makena Hightower; Brian Vaught; Yuhong Chen; Tiffany A Greenwood; Andrew J Schork; Lei Wang; Manjula Mahata; Mats Stridsberg; Srikrishna Khandrika; Nilima Biswas; Maple M Fung; Jill Waalen; Rita P Middelberg; Andrew C Heath; Grant W Montgomery; Nicholas G Martin; John B Whitfield; Dewleen G Baker; Nicholas J Schork; Caroline M Nievergelt; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2012-09-26       Impact factor: 24.094

Review 6.  Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls.

Authors:  Mary Falcone; Ryan M Smith; Meghan J Chenoweth; Abesh Kumar Bhattacharjee; John R Kelsoe; Rachel F Tyndale; Caryn Lerman
Journal:  Neuropsychopharmacology       Date:  2013-06-24       Impact factor: 7.853

Review 7.  Gene-environment studies and borderline personality disorder: a review.

Authors:  Ryan W Carpenter; Rachel L Tomko; Timothy J Trull; Dorret I Boomsma
Journal:  Curr Psychiatry Rep       Date:  2013-01       Impact factor: 5.285

8.  Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing.

Authors:  Esther M Opmeer; Rudie Kortekaas; Marie-José van Tol; Nic J A van der Wee; Saskia Woudstra; Mark A van Buchem; Brenda W J H Penninx; Dick J Veltman; André Aleman
Journal:  Soc Cogn Affect Neurosci       Date:  2013-03-11       Impact factor: 3.436

9.  Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial.

Authors:  Xiaomin Zhang; Qibin Qi; Jun Liang; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Hypertension       Date:  2012-09-10       Impact factor: 10.190

10.  Rescue of infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence.

Authors:  Marcus W Meinhardt; Anita C Hansson; Stephanie Perreau-Lenz; Christina Bauder-Wenz; Oliver Stählin; Markus Heilig; Clive Harper; Karla U Drescher; Rainer Spanagel; Wolfgang H Sommer
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.